Intramedullary Nails Market Size, Share and Global Trend By Product Type (Upper bone extremities, Lower bone extremities), By Material (Titanium, Stainless steel), By End-user (Hospitals, Specialty clinics, Ambulatory surgical centers, Others) and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
In May 2018, OrthoPediatrics Corp. received 510(k) approval from the U.S Food and Drug Administration for the company’s PediNail Intramedullary Nail for kids. Bone injuries of femur, tibia, and others are increasing at an exponential rate acrooss the globe and deformities of femur, humerus, and tibia at birth are also rising among children. Intramedullary nails also are known as intramedullary rods, are metallic rods inserted in the medullary cavity.
Apart from correction of birth deformities, intramedullary nails are also used in the treatment of diaphyseal fracture of the femur, humerus and tibia, femoral neck fracture, intertrochanteric, subtrochanteric, combination fractures, and others. Owing to the advantages of intramedullary nails when compared to plating such as reduced bending loads, decreased infection risk and others, intramedullary nails are getting more preference in the healthcare environment.
To gain extensive insights into the market, Request for Customization
The growth in global intramedullary nails market is attributed to the factors like advantages offered by intramedullary nails plating, increased availability of a variety of intramedullary nails of varying sizes, favoring health reimbursement, the rising incidences of birth deformities of femur, humerus, and tibia among children.
Additionally, the increasing geriatric population is anticipated to propel the growth of intramedullary nails market. Moreover, the emergence of intramedullary nails which are MRI and CT scan friendly is also expected to fuel the global intramedullary nails market during the forecast period.
The stringent government regulations for orthopedic implants and the complications associated with the use of intramedullary nails are factors that may restrict the growth in global intramedullary nails market. For instance, Zimmer Biomet, Inc. sent an urgent Class 2 device recall for the company’s Affixus Hip Fracture Nail owing to the malfunctioning of the components present within the kit.
Key Players Covered
Some of the major companies that are present in the global intramedullary nails market are Stryker, Zimmer Biomet, Smith & Nephew, B. Braun Melsungen AG, Wright Medical Group N.V., MEDIN a.s., Pega Medical Inc., Johnson & Johnson Services Inc. (DePuy Synthes), Orthofix Holdings Inc., Bioimpianti, IMECO S.A. and other players.
SEGMENTATION
SEGMENTATION | DETAILS |
By Product Type | · Upper bone extremities · Lower bone extremities |
By Material | · Titanium · Stainless steel |
By End-user | · Hospitals · Specialty clinics · Ambulatory surgical centers · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
Among material types, titanium is expected to account for the largest share and fastest growing product for the intramedullary nails market due to a number of related advantages that include better biocompatibility and durability.
Key Insights
- Pricing analysis
- Overview of reimbursement scenario for key countries
- Technological advancements in intramedullary nails
- Key industry developments - mergers, acquisitions and partnerships
Regional Analysis
The global intramedullary nails market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global intramedullary nails market during the projected years due to higher adoption of intramedullary nails combined with increased cases of orthopaedic injuries and greater adoption of orthopedic implants. The intramedullary nails market of Europe and the Asia Pacific is estimated to register significant growth in the anticipated years owing to the improvements in health expenditure and active government support.
Key Industry Developments
- In January 2018, OrthoXel DAC announced that the company received the U.S FDA and European CE mark approval for the company’s Apex Tibial Nailing System.
- In February 2018, Orthopedic Designs North America, Inc. received U.S FDA approval for the company’s Talon DistalFix Humeral Nail indicated to aid in the stabilization and alignment of humeral fractures.
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
